The training provided a critical overview of the clinical and legal responsibilities related to MOUD, emphasizing that its implementation is not only a best practice but also a legal requirement under the Americans with Disabilities Act.
Joyce Johnson, Clinical Director at Stepworks, explained the essential role MOUD plays in helping individuals with opioid use disorder during recovery. She addressed misconceptions, such as the false notion that MOUD is trading one drug for another and highlighted its benefits, including reduced withdrawal symptoms, decreased cravings, and improved mental health stability.
Johnson underscored that MOUD is individualized, can be safely used long-term, and significantly reduces post-release overdose deaths and conflicts inside jails.
Carrie Pond and Calesia Henson from the U.S. Attorney’s Office Eastern and Western District of Kentucky followed with a legal perspective, outlining the ADA’s protections for individuals with opioid use disorder.
They stressed that correctional facilities must maintain MOUD treatment initiated prior to incarceration, evaluate inmates for OUD, and avoid discriminatory policies like mandatory medication changes. The DOJ’s 2022 guidance also was discussed, offering clear expectations for compliance.
Participants indicated they received a clearer understanding of MOUD’s value, the legal risks of non-compliance, and action steps to ensure equitable, evidence-based care for incarcerated individuals.
To access a recording of the webinar, click here.
For a copy of the presentation, click here.
